SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-006439
Filing Date
2019-05-09
Accepted
2019-05-09 16:16:27
Documents
71
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cerc10-q20190331.htm 10-Q 1094013
2 EXHIBIT 31.1 q12019cercex-311.htm EX-31.1 16419
3 EXHIBIT 32.1 q12019cercex-321.htm EX-32.1 10240
10 pipelinechart10q1a01.jpg GRAPHIC 195494
11 rdmilestonechart10q1a01.jpg GRAPHIC 151637
  Complete submission text file 0001628280-19-006439.txt   8353862

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cerc-20190331.xml EX-101.INS 1640185
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20190331.xsd EX-101.SCH 66402
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20190331_cal.xml EX-101.CAL 103710
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20190331_def.xml EX-101.DEF 410687
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20190331_lab.xml EX-101.LAB 869383
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20190331_pre.xml EX-101.PRE 534678
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 19810751
SIC: 2834 Pharmaceutical Preparations